A fate worse than death: apoptosis as an oncogenic process (original) (raw)

• Green, D. R. Means to an End: Apoptosis and Other Cell Death Mechanisms (Cold Spring Harbor Laboratory Press, 2011).
  Google Scholar
• Mattson, M. P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120–129 (2000).
  CAS PubMed Google Scholar
• Nagata, S. Apoptosis and autoimmune diseases. Ann. NY Acad. Sci. 1209, 10–16 (2010).
  CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar
• Delbridge, A. R., Grabow, S., Strasser, A. & Vaux, D. L. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat. Rev. Cancer 16, 99–109 (2016).
  CAS PubMed Google Scholar
• Letai, A. G. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat. Rev. Cancer 8, 121–132 (2008).
  CAS PubMed Google Scholar
• FDA approves new drug for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality. FDA http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm495253.htm,
• Roberts, A. W. et al. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 374, 311–322 (2016).
  CAS PubMed Google Scholar
• Taylor, R. C., Cullen, S. P. & Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9, 231–241 (2008).
  CAS PubMed Google Scholar
• Czabotar, P. E., Lessene, G., Strasser, A. & Adams, J. M. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49–63 (2014).
  CAS PubMed Google Scholar
• Tait, S. W. & Green, D. R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621–632 (2010).
  CAS PubMed Google Scholar
• Li, H., Zhu, H., Xu, C. J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491–501 (1998).
  CAS PubMed Google Scholar
• Luo, X., Budihardjo, I., Zou, H., Slaughter, C. & Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481–490 (1998).
  CAS PubMed Google Scholar
• Tait, S. W., Ichim, G. & Green, D. R. Die another way—non-apoptotic mechanisms of cell death. J. Cell Sci. 127, 2135–2144 (2014).
  CAS PubMed PubMed Central Google Scholar
• Gama, V. et al. The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cells. Sci.Signal. 7, ra67 (2014).
  PubMed PubMed Central Google Scholar
• Wright, K. M., Linhoff, M. W., Potts, P. R. & Deshmukh, M. Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. J. Cell Biol. 167, 303–313 (2004).
  CAS PubMed PubMed Central Google Scholar
• Colell, A. et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 129, 983–997 (2007).
  CAS PubMed Google Scholar
• Llambi, F. et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol. Cell 44, 517–531 (2011).
  CAS PubMed PubMed Central Google Scholar
• Oltersdorf, T. et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677–681 (2005).
  CAS PubMed Google Scholar
• Strasser, A., Harris, A. W., Bath, M. L. & Cory, S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331–333 (1990).
  CAS PubMed Google Scholar
• Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440–442 (1988).
  CAS PubMed Google Scholar
• Finch, A. et al. Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms. Cancer Cell 10, 113–120 (2006).
  CAS PubMed Google Scholar
• Yonish-Rouach, E. et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345–347 (1991).
  CAS PubMed Google Scholar
• Ni Chonghaile, T. et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 334, 1129–1133 (2011).
  PubMed Google Scholar
• Montero, J. et al. Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell 160, 977–989 (2015).
  CAS PubMed PubMed Central Google Scholar
• Adams, J. M. & Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324–1337 (2007).
  CAS PubMed PubMed Central Google Scholar
• Certo, M. et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9, 351–365 (2006).
  CAS PubMed Google Scholar
• Lopez, J. & Tait, S. W. Mitochondrial apoptosis: killing cancer using the enemy within. Br. J. Cancer 112, 957–962 (2015).
  CAS PubMed PubMed Central Google Scholar
• Wyllie, A. H. The biology of cell death in tumours. Anticancer Res. 5, 131–136 (1985).
  CAS PubMed Google Scholar
• Naresh, K. N., Lakshminarayanan, K., Pai, S. A. & Borges, A. M. Apoptosis index is a predictor of metastatic phenotype in patients with early stage squamous carcinoma of the tongue: a hypothesis to support this paradoxical association. Cancer 91, 578–584 (2001).
  CAS PubMed Google Scholar
• Jalalinadoushan, M., Peivareh, H. & Azizzadeh Delshad, A. Correlation between apoptosis and histological grade of transitional cell carcinoma of urinary bladder. Urol. J. 1, 177–179 (2004).
  PubMed Google Scholar
• Sun, B. et al. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur. J. Cancer Prev. 15, 258–265 (2006).
  CAS PubMed Google Scholar
• Alcaide, J. et al. The role and prognostic value of apoptosis in colorectal carcinoma. BMC Clin. Pathol. 13, 24 (2013).
  PubMed PubMed Central Google Scholar
• De Jong, J. S., van Diest, P. J. & Baak, J. P. Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br. J. Cancer 82, 368–373 (2000).
  CAS PubMed Google Scholar
• Dawson, S. J. et al. BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br. J. Cancer 103, 668–675 (2010).
  CAS PubMed PubMed Central Google Scholar
• Anagnostou, V. K. et al. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology. BMC Cancer 10, 186 (2010).
  PubMed PubMed Central Google Scholar
• Renouf, D. J. et al. BCL-2 expression is prognostic for improved survival in non-small cell lung cancer. J. Thorac. Oncol. 4, 486–491 (2009).
  PubMed Google Scholar
• Hogarth, L. A. & Hall, A. G. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Blood 93, 2671–2678 (1999).
  CAS PubMed Google Scholar
• Kaparou, M. et al. Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features. Genet. Mol. Biol. 36, 7–11 (2013).
  CAS PubMed PubMed Central Google Scholar
• Del Gaizo Moore, V. et al. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J. Clin. Invest. 117, 112–121 (2007).
  CAS PubMed PubMed Central Google Scholar
• Ryoo, H. D., Gorenc, T. & Steller, H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev. Cell 7, 491–501 (2004).
  CAS PubMed Google Scholar
• Huh, J. R., Guo, M. & Hay, B. A. Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr. Biol. 14, 1262–1266 (2004).
  CAS PubMed Google Scholar
• Perez-Garijo, A., Martin, F. A. & Morata, G. Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila. Development 131, 5591–5598 (2004).
  CAS PubMed Google Scholar
• Li, F. et al. Apoptotic cells activate the “phoenix rising” pathway to promote wound healing and tissue regeneration. Sci. Signal. 3, ra13 (2010).
  PubMed PubMed Central Google Scholar
• Atsumi, G. et al. Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation. J. Biol. Chem. 273, 13870–13877 (1998).
  CAS PubMed Google Scholar
• Revesz, L. Effect of tumour cells killed by X-rays upon the growth of admixed viable cells. Nature 178, 1391–1392 (1956).
  CAS PubMed Google Scholar
• Chaurio, R. et al. UVB-irradiated apoptotic cells induce accelerated growth of co-implanted viable tumor cells in immune competent mice. Autoimmunity 46, 317–322 (2013).
  CAS PubMed Google Scholar
• Huang, Q. et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med. 17, 860–866 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kurtova, A. V. et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature 517, 209–213 (2015).
  CAS PubMed Google Scholar
• Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257–1270 (2015).
  CAS PubMed PubMed Central Google Scholar
• Kruiswijk, F., Labuschagne, C. F. & Vousden, K. H. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16, 393–405 (2015).
  CAS PubMed Google Scholar
• Bondar, T. & Medzhitov, R. p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell 6, 309–322 (2010).
  CAS PubMed PubMed Central Google Scholar
• Marusyk, A., Porter, C. C., Zaberezhnyy, V. & DeGregori, J. Irradiation selects for p53-deficient hematopoietic progenitors. PLoS Biol. 8, e1000324 (2010).
  PubMed PubMed Central Google Scholar
• Villunger, A. et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302, 1036–1038 (2003).
  CAS PubMed Google Scholar
• Jeffers, J. R. et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321–328 (2003).
  CAS PubMed Google Scholar
• Garrison, S. P. et al. Selection against PUMA gene expression in _Myc_-driven B-cell lymphomagenesis. Mol. Cell. Biol. 28, 5391–5402 (2008).
  CAS PubMed PubMed Central Google Scholar
• Michalak, E. M. et al. Puma and to a lesser extent Noxa are suppressors of _Myc_-induced lymphomagenesis. Cell Death Differ. 16, 684–696 (2009).
  CAS PubMed Google Scholar
• Michalak, E. M. et al. Apoptosis-promoted tumorigenesis: γ-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev. 24, 1608–1613 (2010).
  CAS PubMed PubMed Central Google Scholar
• Labi, V. et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev. 24, 1602–1607 (2010).
  CAS PubMed PubMed Central Google Scholar
• Qiu, W. et al. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology 54, 1249–1258 (2011).
  CAS PubMed Google Scholar
• Pierce, R. H., Vail, M. E., Ralph, L., Campbell, J. S. & Fausto, N. Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci. Am. J. Pathol. 160, 1555–1560 (2002).
  CAS PubMed PubMed Central Google Scholar
• Orlik, J. et al. The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice. Hepatology 62, 816–828 (2015).
  CAS PubMed Google Scholar
• Bai, L., Ni, H. M., Chen, X., DiFrancesca, D. & Yin, X. M. Deletion of Bid impedes cell proliferation and hepatic carcinogenesis. Am. J. Pathol. 166, 1523–1532 (2005).
  CAS PubMed PubMed Central Google Scholar
• Bejar, R. & Steensma, D. P. Recent developments in myelodysplastic syndromes. Blood 124, 2793–2803 (2014).
  CAS PubMed Google Scholar
• Ma, X. Epidemiology of myelodysplastic syndromes. Am. J. Med. 125, S2–S5 (2012).
  PubMed PubMed Central Google Scholar
• Godley, L. A. & Larson, R. A. Therapy-related myeloid leukemia. Semin. Oncol. 35, 418–429 (2008).
  CAS PubMed PubMed Central Google Scholar
• Guirguis, A. A. et al. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia. Cell Death Differ. 23, 1049–1059 (2016).
  CAS PubMed PubMed Central Google Scholar
• Slape, C. I. et al. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome. Blood 120, 2475–2483 (2012).
  CAS PubMed PubMed Central Google Scholar
• Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907–917 (2015).
  CAS PubMed PubMed Central Google Scholar
• Tang, J. et al. Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition. Mol. Med. Rep. 12, 7907–7914 (2015).
  CAS PubMed PubMed Central Google Scholar
• Tardaguila, M. & Manes, S. CX3CL1 at the crossroad of EGF signals: relevance for the progression of ERBB2 breast carcinoma. Oncoimmunology 2, e25669 (2013).
  PubMed PubMed Central Google Scholar
• Elliott, M. R. et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461, 282–286 (2009).
  CAS PubMed PubMed Central Google Scholar
• Spychala, J. Tumor-promoting functions of adenosine. Pharmacol. Ther. 87, 161–173 (2000).
  CAS PubMed Google Scholar
• Gregory, C. D. & Pound, J. D. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J. Pathol. 223, 177–194 (2011).
  CAS PubMed Google Scholar
• Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49–61 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ford, C. A. et al. Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma. Curr. Biol. 25, 577–588 (2015).
  CAS PubMed PubMed Central Google Scholar
• Stanford, J. C. et al. Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. J. Clin. Invest. 124, 4737–4752 (2014).
  CAS PubMed PubMed Central Google Scholar
• Callihan, E. B. et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res. Treat. 138, 549–559 (2013).
  PubMed PubMed Central Google Scholar
• Schedin, P. J. & Watson, C. J. The complexity of the relationships between age at first birth and breast cancer incidence curves implicate pregnancy in cancer initiation as well as promotion of existing lesions. J. Mammary Gland Biol. Neoplasia 14, 85–86 (2009).
  PubMed Google Scholar
• Ichim, G. et al. Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol. Cell 57, 860–872 (2015).
  CAS PubMed PubMed Central Google Scholar
• Lovric, M. M. & Hawkins, C. J. TRAIL treatment provokes mutations in surviving cells. Oncogene 29, 5048–5060 (2010).
  CAS PubMed PubMed Central Google Scholar
• Liu, X. et al. Caspase-3 promotes genetic instability and carcinogenesis. Mol. Cell 58, 284–296 (2015).
  CAS PubMed PubMed Central Google Scholar
• Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I. & Green, D. R. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2, 156–162 (2000).
  CAS PubMed Google Scholar
• Rehm, M., Dussmann, H. & Prehn, J. H. Real-time single cell analysis of Smac/DIABLO release during apoptosis. J. Cell Biol. 162, 1031–1043 (2003).
  CAS PubMed PubMed Central Google Scholar
• Rehm, M., Huber, H. J., Dussmann, H. & Prehn, J. H. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J. 25, 4338–4349 (2006).
  CAS PubMed PubMed Central Google Scholar
• Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5, 157–163 (1999).
  CAS PubMed Google Scholar
• Albeck, J. G. et al. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. Cell 30, 11–25 (2008).
  CAS PubMed PubMed Central Google Scholar
• Enari, M. et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43–50 (1998).
  CAS PubMed Google Scholar
• Galluzzi, L., Larochette, N., Zamzami, N. & Kroemer, G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 25, 4812–4830 (2006).
  CAS PubMed Google Scholar
• Tait, S. W. et al. Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev. Cell 18, 802–813 (2010).
  CAS PubMed PubMed Central Google Scholar
• Orth, J. D., Loewer, A., Lahav, G. & Mitchison, T. J. Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol. Biol. Cell 23, 567–576 (2012).
  CAS PubMed PubMed Central Google Scholar
• Colin, D. J., Hain, K. O., Allan, L. A. & Clarke, P. R. Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins. Open Biol. 5, 140156 (2015).
  PubMed PubMed Central Google Scholar
• Luke, J. J., Van De Wetering, C. I. & Knudson, C. M. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability. Cell Death Differ. 10, 740–748 (2003).
  CAS PubMed Google Scholar
• Rao, R. C. & Dou, Y. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat. Rev. Cancer 15, 334–346 (2015).
  CAS PubMed PubMed Central Google Scholar
• Gole, B. & Wiesmuller, L. Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism. Front. Cell Dev. Biol. 3, 41 (2015).
  PubMed PubMed Central Google Scholar
• Hars, E. S., Lyu, Y. L., Lin, C. P. & Liu, L. F. Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. Cancer Res. 66, 8975–8979 (2006).
  CAS PubMed Google Scholar
• Sim, S. P. & Liu, L. F. Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J. Biol. Chem. 276, 31590–31595 (2001).
  CAS PubMed Google Scholar
• Betti, C. J., Villalobos, M. J., Diaz, M. O. & Vaughan, A. T. Apoptotic stimuli initiate MLL–AF9 translocations that are transcribed in cells capable of division. Cancer Res. 63, 1377–1381 (2003).
  CAS PubMed Google Scholar
• Trinchieri, G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 30, 677–706 (2012).
  CAS PubMed Google Scholar
• Fresquet, V., Rieger, M., Carolis, C., Garcia-Barchino, M. J. & Martinez-Climent, J. A. Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma. Blood 123, 4111–4119 (2014).
  CAS PubMed Google Scholar
• Song, J. H., Kandasamy, K., Zemskova, M., Lin, Y. W. & Kraft, A. S. The BH3 mimetic ABT-737 induces cancer cell senescence. Cancer Res. 71, 506–515 (2011).
  CAS PubMed Google Scholar
• Fuchs, Y. & Steller, H. Programmed cell death in animal development and disease. Cell 147, 742–758 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hardwick, J. M. & Soane, L. Multiple functions of BCL-2 family proteins. Cold Spring Harb. Perspect. Biol. 5, a008722 (2013).
  PubMed PubMed Central Google Scholar
• Hyman, B. T. & Yuan, J. Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat. Rev. Neurosci. 13, 395–406 (2012).
  CAS PubMed Google Scholar
• Kilbride, S. M. & Prehn, J. H. Central roles of apoptotic proteins in mitochondrial function. Oncogene 32, 2703–2711 (2013).
  CAS PubMed Google Scholar
• Bonneau, B., Prudent, J., Popgeorgiev, N. & Gillet, G. Non-apoptotic roles of Bcl-2 family: the calcium connection. Biochim. Biophys. Acta 1833, 1755–1765 (2013).
  CAS PubMed Google Scholar
• Pedro, J. M. et al. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2–BECN1 complex and autophagy. Autophagy 11, 452–459 (2015).
  PubMed PubMed Central Google Scholar
• Lindqvist, L. M., Heinlein, M., Huang, D. C. & Vaux, D. L. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak. Proc. Natl Acad. Sci. USA 111, 8512–8517 (2014).
  CAS PubMed PubMed Central Google Scholar
• Choi, S. et al. Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nat. Commun. 7, 10384 (2016).
  CAS PubMed PubMed Central Google Scholar
• Dimberg, L. Y. et al. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 32, 1341–1350 (2013).
  CAS PubMed Google Scholar
• Von Karstedt, S. et al. Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell 27, 561–573 (2015).
  CAS PubMed PubMed Central Google Scholar
• Somasekharan, S. P. et al. TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis. Apoptosis 18, 324–336 (2013).
  CAS PubMed Google Scholar
• Ehrenschwender, M. et al. Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation. Cell Death Differ. 17, 1435–1447 (2010).
  CAS PubMed Google Scholar
• Peter, M. E. et al. The role of CD95 and CD95 ligand in cancer. Cell Death Differ. 22, 885–886 (2015).
  CAS PubMed PubMed Central Google Scholar
• Chen, L. et al. CD95 promotes tumour growth. Nature 465, 492–496 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hadji, A. et al. Death induced by CD95 or CD95 ligand elimination. Cell Rep. 7, 208–222 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ceppi, P. et al. CD95 and CD95L promote and protect cancer stem cells. Nat. Commun. 5, 5238 (2014).
  CAS PubMed Google Scholar
• Fanidi, A., Harrington, E. A. & Evan, G. I. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359, 554–556 (1992).
  CAS PubMed Google Scholar
• Schmitt, C. A., Rosenthal, C. T. & Lowe, S. W. Genetic analysis of chemoresistance in primary murine lymphomas. Nat. Med. 6, 1029–1035 (2000).
  CAS PubMed Google Scholar
• Letai, A., Sorcinelli, M. D., Beard, C. & Korsmeyer, S. J. Antiapoptotic BCL-2 is required for maintenance of a model leukemia. Cancer Cell 6, 241–249 (2004).
  CAS PubMed Google Scholar
• Kelly, G. L. et al. Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53. Genes Dev. 28, 58–70 (2014).
  CAS PubMed PubMed Central Google Scholar
• Garcia, E. L. & Mills, A. A. Getting around lethality with inducible Cre-mediated excision. Semin. Cell Dev. Biol. 13, 151–158 (2002).
  CAS PubMed Google Scholar
• Lopez, J. et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat. Commun. 7, 10538 (2016).
  CAS PubMed PubMed Central Google Scholar
• Zhang, J. et al. Visualization of caspase-3-like activity in cells using a genetically encoded fluorescent biosensor activated by protein cleavage. Nat. Commun. 4, 2157 (2013).
  PubMed Google Scholar
• Earley, S. et al. In vivo imaging of drug-induced mitochondrial outer membrane permeabilization at single-cell resolution. Cancer Res. 72, 2949–2956 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ellenbroek, S. I. & van Rheenen, J. Imaging hallmarks of cancer in living mice. Nat. Rev. Cancer 14, 406–418 (2014).
  CAS PubMed Google Scholar
• Janssen, A., Beerling, E., Medema, R. & van Rheenen, J. Intravital FRET imaging of tumor cell viability and mitosis during chemotherapy. PLoS ONE 8, e64029 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kim, K. W., Moretti, L. & Lu, B. M867, a novel selective inhibitor of caspase-3 enhances cell death and extends tumor growth delay in irradiated lung cancer models. PLoS ONE 3, e2275 (2008).
  PubMed PubMed Central Google Scholar
• Werthmoller, N., Frey, B., Wunderlich, R., Fietkau, R. & Gaipl, U. S. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner. Cell Death Dis. 6, e1761 (2015).
  CAS PubMed PubMed Central Google Scholar
• Rongvaux, A. et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159, 1563–1577 (2014).
  CAS PubMed PubMed Central Google Scholar
• White, M. J. et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549–1562 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ahn, J. et al. Inflammation-driven carcinogenesis is mediated through STING. Nat. Commun. 5, 5166 (2014).
  CAS PubMed Google Scholar
• Ahn, J., Konno, H. & Barber, G. N. Diverse roles of STING-dependent signaling on the development of cancer. Oncogene 34, 5302–5308 (2015).
  CAS PubMed PubMed Central Google Scholar
• Xiang, J., Chao, D. T. & Korsmeyer, S. J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl Acad. Sci. USA 93, 14559–14563 (1996).
  CAS PubMed PubMed Central Google Scholar
• Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).
  CAS PubMed Google Scholar
• Swann, J. B. & Smyth, M. J. Immune surveillance of tumors. J. Clin. Invest. 117, 1137–1146 (2007).
  CAS PubMed PubMed Central Google Scholar
• Pyonteck, S. M. et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19, 1264–1272 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ries, C. H. et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25, 846–859 (2014).
  CAS PubMed Google Scholar
• Fulda, S. & Vucic, D. Targeting IAP proteins for therapeutic intervention in cancer. Nat. Rev. Drug Discov. 11, 109–124 (2012).
  CAS PubMed Google Scholar
• Tait, S. W. & Green, D. R. Mitochondrial regulation of cell death. Cold Spring Harb. Perspect. Biol. 5, a008706 (2013).
  PubMed PubMed Central Google Scholar
• Hellwig, C. T. et al. Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand/cycloheximide-induced caspase activities during apoptosis initiation. J. Biol. Chem. 283, 21676–21685 (2008).
  CAS PubMed Google Scholar
• Hellwig, C. T. et al. Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation. J. Cell Sci. 123, 1401–1406 (2010).
  CAS PubMed Google Scholar
• Desagher, S. et al. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell 8, 601–611 (2001).
  CAS PubMed Google Scholar
• Wolan, D. W., Zorn, J. A., Gray, D. C. & Wells, J. A. Small-molecule activators of a proenzyme. Science 326, 853–858 (2009).
  CAS PubMed PubMed Central Google Scholar
• Vakkila, J. & Lotze, M. T. Inflammation and necrosis promote tumour growth. Nat. Rev. Immunol. 4, 641–648 (2004).
  CAS PubMed Google Scholar
• Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).
  CAS PubMed PubMed Central Google Scholar
• Berardo, M. D. et al. bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 82, 1296–1302 (1998).
  CAS PubMed Google Scholar
• Vargas-Roig, L. M. et al. Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy. Mol. Oncol. 2, 102–111 (2008).
  PubMed PubMed Central Google Scholar
• Neri, A. et al. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer. Breast Cancer Res. Treat. 99, 77–83 (2006).
  CAS PubMed Google Scholar
• Meterissian, S. H. et al. Bcl-2 is a useful prognostic marker in Dukes' B colon cancer. Ann. Surg. Oncol. 8, 533–537 (2001).
  CAS PubMed Google Scholar
• Watson, N. F. et al. Evidence that the p53 negative/Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients. World J. Surg. Oncol. 3, 47 (2005).
  PubMed PubMed Central Google Scholar
• Tomita, M. et al. Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer. Eur. J. Surg. Oncol. 29, 654–657 (2003).
  CAS PubMed Google Scholar
• Pillai, K., Pourgholami, M. H., Chua, T. C. & Morris, D. L. Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma? Am. J. Cancer Res. 3, 312–322 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kohler, T. et al. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML). Leukemia 16, 22–29 (2002).
  CAS PubMed Google Scholar
• Bairey, O., Zimra, Y., Shaklai, M., Okon, E. & Rabizadeh, E. Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas. Clin. Cancer Res. 5, 2860–2866 (1999).
  CAS PubMed Google Scholar